Compare Reddit Inc (RDDT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Reddit Inc vs Recursion Pharmaceuticals Inc — how do they compare? Reddit Inc trades at $170.64 (market cap $35.78B), while Recursion Pharmaceuticals Inc trades at $2.99 (market cap $1.63B). The key difference: Reddit Inc is far larger — about 22× Recursion Pharmaceuticals Inc's market cap, and Reddit Inc is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| RDDT | RXRX | |
|---|---|---|
Market Cap | $35.78B | $1.63B |
Sector | Media | Health |
52-Week High | $270.71 | $6.79 |
52-Week Low | $121.84 | $2.84 |
Enterprise Value | $33.03B | $1.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Reddit (RDDT) trades at $181.67, up 0.21% today, with a bearish technical signal but strong fundamentals including 91.37% gross margins and recent earnings beats. Analyst consensus is bullish with a $236.89 price target, and institutional interest is rising, as seen with Andra AP fonden's 152.6% stake increase in Q1 2026 (SEC filing, July 21, 2026).
The outlook is positive due to robust revenue growth and AI initiatives, but risks include high valuation multiples and competitive pressures. Near-term focus is on Q2 2026 earnings due July 30, 2026, which could drive volatility.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
